Evidence map›Paper›PMID 31779091›Full record

ArticleMolecules (Basel, Switzerland)2019

Synthesis, Antimicrobial, and Anti-Proliferative Activities of Novel 4-(Adamantan-1-yl)-1-arylidene-3-thiosemicarbazides, 4-Arylmethyl

Aamal A Al-Mutairi, Monirah A Al-Alshaikh, Fatmah A M Al-Omary, Hanan M Hassan, Areej M El-Mahdy, Ali A El-Emam

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Structural isomerisation affects the antitubercular activity of adamantyl-isoxyl adducts.Journal of enzyme inhibition and medicinal chemistry · 2025
    Article
  3. Article
  4. Desulfurization of thiosemicarbazones: the role of metal ions and biological implications.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aamal A Al-MutairiDepartment of Chemistry, College of Sciences, Al Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.
Monirah A Al-AlshaikhDepartment of Chemistry, College of Sciences, King Saud University, Riyadh 11451, Saudi Arabia.
Fatmah A M Al-OmaryDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Hanan M HassanDepartment of Pharmacology and Biochemistry, Department of Pharmacology and Biochemistry, College of Pharmacy, Delta University for Science and Technology, International Costal Road, Gamasa City, Mansoura 11152, Dakahliya, Egypt.
Areej M El-MahdyDepartment of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.
Ali A El-EmamDepartment of Medicinal Chemistry, Faculty of Pharmacy, University of Mansoura, Mansoura 35516, Egypt.

Funding

Female Center for Scientific and Medical Colleges, King Saud University NA
6 · The paper itself

Abstract

The reaction of 4-(adamantan-1-yl)-3-thiosemicarbazide

Indexed as

Anti-Infective AgentsCandida albicansCell Line, TumorCell ProliferationGram-Negative BacteriaGram-Positive BacteriaHL-60 CellsHT29 CellsHumansMCF-7 CellsMicrobial Sensitivity TestsPiperidinesSemicarbazidesStructure-Activity RelationshipAnti-Infective AgentspiperidinePiperidinesSemicarbazidesthiosemicarbazideadamantaneantimicrobial activityanti-proliferative activitycarbothioimidatesthiazolidin-4-ones

Identifiers

PMID31779091
PMCPMC6930481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.